OIS Co-Chair Emmett Cunningham Delivers Comprehensive Review of Ophthalmology Innovation

OIS Co-chair and Clarus Funds Managing Director Emmett T. Cunningham Jr., MD, PhD, MPH, delivered a complete overview of the new ophthalmology treatments. In this annual address, Cunningham, Managing Director at Clarus Funds, reviews the state of the FDA, ongoing clinical trials and important financial metrics for ophthalmology innovation. He also identified companies that he sees as “hot and noteworthy.” Watch to see what we can expect to see in 2018.